Sheila Jacobs

Researchers conducted a post hoc analysis to compare the performance of 2 disease activity scores — BASDAI and ASDAS — in assessing axial involvement in patients with PsA receiving treatment with guselkumab.

Researchers estimated the proportion of men and women with COVID-19, 20 years of age or younger or 20 years of age and older, who experienced long COVID symptoms in 2020 and 2021, and assessed their symptom severity and expected duration.

Researchers assessed whether small fiber involvement in patients with typical CIDP and CIDP variants correlated with disease activity and with clinical outcome measures.

A study was conducted to determine if pitavastatin plus ezetimibe decreases LDL-C more than either medication as a monotherapy.

Researchers developed a novel patient-reported outcome instrument to assess the severity and impact of systemic sclerosis-associated Raynaud phenomenon.

Pulse oximetry accuracy in those with darker skin tones and the clinical implications of device inaccuracy was the subject of an evidence-based literature review.

Researchers investigated the association between frequency of self-reported distressing dreams and the risk for cognitive decline and incident dementia in men and women without cognitive impairment or PD.

Researchers identified risk factors that predict risk of progression from discoid lupus erythematosus to severe systemic lupus erythematosus.

Researchers identified 2 cases of encephalomyelitis associated with acute monkeypox virus in the US.

Researchers assessed the effect of holding methotrexate for 2 weeks after the COVID-19 vaccine on antibody titers and rate of disease flares.